LSE - Delayed Quote GBp
N4 Pharma Plc (N4P.L)
0.4788
+0.0038
+(0.80%)
As of 11:28:35 AM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Nigel James Theobald | Founder, CEO & Executive Director | 82.5k | -- | 1964 |
| Mr. Luke Sebastian Cairns | Executive Director | 44k | -- | 1978 |
| Rob Harris | Head of CMC Development | -- | -- | -- |
| Dr. Andrew Leishman | Consultant | -- | -- | -- |
N4 Pharma Plc
60 Gracechurch Street
6th Floor
London, EC3V 0HR
United Kingdom
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 5
Description
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom. It develops Nuvec, which offers silica nanoparticles with irregular surface structure and polyethyleneimine that traps and protects nucleic acid; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene for the treatment of glaucoma. The company was incorporated in 1979 and is based in London, the United Kingdom.
Corporate Governance
N4 Pharma Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
June 3, 2025 at 7:30 AM UTC - June 4, 2025 at 7:30 AM UTC
N4 Pharma Plc Earnings Date
Recent Events
May 19, 1997 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
HMDCF HUTCHMED (China) Limited
3.2050
-15.99%
SBX.BE SynBiotic SE
3.1200
-4.44%
TBET Tibet Pharmaceuticals, Inc.
0.0000
0.00%
8BN.BE Optimi Health Corp
0.1150
+7.48%
2HQ.DU Tilray Brands Inc
0.3640
+4.33%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
0.00%
SFZNz.XC
BNXTF BioNxt Solutions Inc.
0.4000
+4.38%
EAH.L ECO Animal Health Group plc
61.50
+0.82%
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,513.65
+1.12%